DNA microarrays in neuropsychopharmacology

Trends in Pharmacological Sciences

Volumn 22, Issue 8, 2001, Pages 426-436

  Marcotte, Eric R ^a   Srivastava, Lalit K ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MYELIN BASIC PROTEIN; NERVE CELL ADHESION MOLECULE; OLIGONUCLEOTIDE; PSYCHOTROPIC AGENT; TETRAHYDROCANNABINOL;

ACCURACY; AGING; ALZHEIMER DISEASE; CANCER; DEGENERATIVE DISEASE; DNA MICROARRAY; DRUG DESIGN; DRUG EFFECT; GENE EXPRESSION; GENE FUNCTION; GENE MAPPING; GENETIC SCREENING; GENETICS; GENOME; HUMAN; MULTIPLE SCLEROSIS; NERVE FUNCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SCHIZOPHRENIA; TOXICOLOGY;

AGING; ANIMALS; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPHARMACOLOGY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS;

EID: 0035424371     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01741-7     Document Type: Review

References (135)

1. High throughput analysis of gene expression in the human brain
2. Options available - From start to finish - For obtaining expression data by microarray
3. High density synthetic oligonucleotide arrays
4. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
5. Expression profiling in cancer using cDNA microarrays
6. Gene expression profiles in normal and cancer cells
7. Genome changes and gene expression in human solid tumors
8. Exploring the new world of the genome with DNA microarrays
9. Pharmacogenetics and the practice of medicine
10. Prospects for whole-genome linkage disequilibrium mapping of common disease genes
11. Future directions of research in statistical genetics
12. The 'chip' as a specific genetic tool
13. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays
14. How the host 'sees' pathogens: Global gene expression responses to infection
15. Genomic views of the immune system
16. Prospective use of DNA microarrays for evaluating renal function and disease
17. Application of microarray assay to nephrology
18. A bioinformatics approach to investigating developmental pathways in the kidney and other tissues
19. Microarray-based detection of select cardiovascular disease markers
20. Genetic susceptibility to atherosclerosis: Insights from mice
21. Altered patterns of gene expression in response to myocardial infarction
22. Timely toxicology
23. Microarrays and toxicology: The advent of toxicogenomics
24. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation
25. Gene expression microarray data analysis for toxicology profiling
26. DNA microarrays in drug discovery and development
27. Knowledge discovery in gene-expression-microarray data: Mining the information output of the genome
28. Recent progress in biomolecular engineering
29. The impact of genomics on therapeutic drug development
30. The integration of microarray information in the drug development process
31. Analysis of drug pharmacology towards predicting drug behavior by expression profiling using high-density oligonucleotide arrays
32. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells
33. Development of a toxicological gene array and quantitative assessment of this technology
34. Pharmacogenomics and schizophrenia
35. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays
36. Mapping of complex traits by single-nucleotide polymorphisms
37. The essence of SNPs
38. Drug firms to create public database of genetic mutations
39. Genes, themes and microarrays: Using information retrieval for large- scale gene analysis
40. From the cover: Regional and strain-specific gene expression mapping in the adult mouse brain
41. Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection
42. Fundamental patterns underlying gene expression profiles: Simplicity from complexity
43. Generation of patterns from gene expression data by assigning confidence to differentially expressed genes
44. Importance of replication in microarray gene expression studies: Statistical methods and evidence from repetitive cDNA hybridizations
45. Coupled two-way clustering analysis of gene microarray data
46. Cluster analysis and display of genome-wide expression patterns
47. Large-scale temporal gene expression mapping of central nervous system development
48. The stanford microarray database
49. Subtractive cloning: Past, present, and future
50. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
51. Serial analysis of gene expression
52. Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis
53. Printing proteins as microarrays for high-throughput function determination
54. Proteomics to study genes and genomes
55. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions
56. Technology for microarray analysis of gene expression
57. Making and reading microarrays
58. Laser capture microdissection: Molecular analysis of tissue
59. Laser capture microdissection
60. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis - Preliminary findings
61. Proteomics in molecular medicine: Applications in central nervous systems disorders
62. Immuno-LCM: Laser capture microdissection of immunostained frozen sections for mRNA analysis
63. IF-LCM: Laser capture microdissection of immunofluorescently defined cells for mRNA analysis rapid communication
64. Quantitation of mRNA by the polymerase chain reaction
65. Cloning of genes from single neurons
66. Amplification of genes, single transcripts and cDNA libraries from one cell and direct sequence analysis of amplified products derived from one molecule
67. A concise guide to cDNA microarray analysis
68. Microarray analysis of the transcriptional network controlled by the photoreceptor homeobox gene Crx
69. Use of SMART - Generated cDNA for differential gene expression studies
70. Analysis of gene expression in human bullous keratopathy corneas containing limiting amounts of RNA
71. Representative cDNA libraries and their utility in gene expression profiling
72. Microarray hybridization with fractionated cDNA: Enhanced identification of differentially expressed genes
73. PCR amplification on a microarray of gel-immobilized oligonucleotides: Detection of bacterial toxin- and drug-resistant genes and their mutations
74. Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format
75. Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication
76. Analysis of gene expression in single live neurons
77. Laser capture microdissection-generated target sample for high-density oligonucleotide array hybridization
78. Gene expression profiles of laser-captured adjacent neuronal subtypes
79. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons
80. Isolation of novel mouse genes differentially expressed in brain using cDNA microarray
81. Developing mouse models of aging: A consideration of strain differences in age-related behavioral and neural parameters
82. Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies
83. Effects of environmental enrichment on gene expression in the brain
84. Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia
85. Gene expression in the rat supraoptic nucleus induced by chronic hyperosmolality versus hyposmolality
86. Addiction, dopamine, and the molecular mechanisms of memory
87. Genes and addiction
88. Large-scale analysis of gene expression changes during acute and chronic exposure to Δ9-THC in rats
89. Identification of a novel gene with RING-H2 finger motif induced after chronic antidepressant treatment in rat brain
90. The association between parkinsonism, Alzheimer's disease, and mortality: A comprehensive approach
91. Some developments in brain ageing and dementia
92. Mitotic misregulation and human aging
93. Gene-expression profile of the ageing brain in mice
94. Gene expression profile of aging and its retardation by caloric restriction
95. Dietary restriction benefits learning and motor performance of aged mice
96. Dietary restriction suppresses age-related changes in dendritic spines
97. Long-term potentiation is lost in aged rats but preserved by calorie restriction
98. Emerging neuroprotective strategies for Alzheimer's disease: Dietary restriction, telomerase activation, and stem cell therapy
99. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease
100. cDNA expression arrays reveal incomplete reversal of age-related changes in gene expression by calorie restriction
101. Identification of age-dependent changes in expression of senescence-accelerated mouse (SAMP8) hippocampal proteins by expression array analysis
102. Reactivity to novelty in cognitively-impaired and cognitively- unimpaired aged rats and young rats
103. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays
104. Microglial activation precedes acute neurodegeneration in sandhoff disease and is suppressed by bone marrow transplantation
105. The endosomal-lysosomal system of neurons: New roles
106. Alzheimer's disease: A cell biological perspective
107. The essential role of inflammation and induced gene expression in the pathogenic pathway of Alzheimer's disease
108. Chemokines and chemokine receptors in the CNS: A possible role in neuroinflammation and patterning
109. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
110. A β peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
111. A β peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
112. Examining functional genomic expression in schizophrenia with cDNA microarrays
113. RNA profiling in neuro-psychiatric disorders
114. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
115. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity
116. Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex
117. Age-related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics
118. Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients
119. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia
120. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
121. Gene expression in human alcoholism: Microarray analysis of frontal cortex
122. Identifying a series of candidate genes for mania and psychosis: A convergent functional genomics approach
123. Gene expression changes in adult prefrontal cortex and nucleus accumbens following neonatal ventral hippocampal lesions
124. Animal models of schizophrenia: A critical review
125. To model a psychiatric disorder in animals. Schizophrenia as a reality test
126. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia
127. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus
128. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat
129. Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats
130. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens
131. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine
132. Disruption of latent inhibition in rats with postnatal hippocampal lesions